Photo by sxy_selia from unsplash
Glioblastoma (GBM) remains the most biologically aggressive subtype of gliomas with an average survival of 10 to 12 months. Considering that the overall survival (OS) of each GBM patient is… Click to show full abstract
Glioblastoma (GBM) remains the most biologically aggressive subtype of gliomas with an average survival of 10 to 12 months. Considering that the overall survival (OS) of each GBM patient is a key factor in the treatment of individuals, it is meaningful to predict the survival probability for GBM patients newly diagnosed in clinical practice.
Keywords:
gene prognostic;
glioblastoma;
prognostic nomogram;
nomogram predicting;
survival probability
Journal Title: Brain and Behavior
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Brain and Behavior
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!